Abstract
The motility and morphogenesis of endothelial cells is controlled by spatio-temporally regulated activation of integrin adhesion receptors, and integrin activation is stimulated by major determinants of vascular remodelling. In order for endothelial cells to be responsive to changes in activator gradients, the adhesiveness of these cells to the extracellular matrix must be dynamic, and negative regulators of integrins could be required. Here we show that during vascular development and experimental angiogenesis, endothelial cells generate autocrine chemorepulsive signals of class 3 semaphorins (SEMA3 proteins) that localize at nascent adhesive sites in spreading endothelial cells. Disrupting endogenous SEMA3 function in endothelial cells stimulates integrin-mediated adhesion and migration to extracellular matrices, whereas exogenous SEMA3 proteins antagonize integrin activation. Misexpression of dominant negative SEMA3 receptors in chick embryo endothelial cells locks integrins in an active conformation, and severely impairs vascular remodelling. Sema3a null mice show vascular defects as well. Thus during angiogenesis endothelial SEMA3 proteins endow the vascular system with the plasticity required for its reshaping by controlling integrin function.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
13 December 2022
Editor’s Note: Readers are alerted that the reliability of data presented in this manuscript is currently in question. Appropriate editorial action will be taken once this matter is resolved.
21 February 2024
An Editorial Expression of Concern to this paper has been published: https://doi.org/10.1038/s41586-024-07195-5
References
Yancopoulos, G. D. et al. Vascular-specific growth factors and blood vessel formation. Nature 407, 242–248 (2000)
Stupack, D. G. & Cheresh, D. A. ECM remodeling regulates angiogenesis: Endothelial integrins look for new ligands. Sci. STKE 119, PE7 (2002)
Brooks, P. C., Clark, R. A. & Cheresh, D. A. Requirement of vascular integrin αvβ3 for angiogenesis. Science 264, 569–571 (1994)
Brooks, P. C. et al. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157–1164 (1994)
Friedlander, M. et al. Definition of two angiogenic pathways by distinct αv integrins. Science 270, 1500–1502 (1995)
George, E. L., Georges-Labouesse, E. N., Patel-King, R. S., Rayburn, H. & Hynes, R. O. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119, 1079–1091 (1993)
Francis, S. E. et al. Central roles of α5β1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler. Thromb. Vasc. Biol. 22, 927–933 (2002)
Bader, B. L., Rayburn, H., Crowley, D. & Hynes, R. O. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all αv integrins. Cell 95, 507–519 (1998)
Stupack, D. G., Puente, X. S., Boutsaboualoy, S., Storgard, C. M. & Cheresh, D. A. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 155, 459–470 (2001)
Hynes, R. O. Integrins: Bidirectional, allosteric signaling machines. Cell 110, 673–687 (2002)
Kiosses, W. B., Shattil, S. J., Pampori, N. & Schwartz, M. A. Rac recruits high-affinity integrin αvβ3 to lamellipodia in endothelial cell migration. Nature Cell Biol. 3, 316–320 (2001)
Martin-Bermudo, M. D., Dunin-Borkowski, O. M. & Brown, N. H. Modulation of integrin activity is vital for morphogenesis. J. Cell Biol. 141, 1073–1081 (1998)
Tzima, E., del Pozo, M. A., Shattil, S. J., Chien, S. & Schwartz, M. A. Activation of integrins in endothelial cells by fluid shear stress mediates Rho-dependent cytoskeletal alignment. EMBO J. 20, 4639–4647 (2001)
Byzova, T. V. et al. A mechanism for modulation of cellular responses to VEGF: Activation of the integrins. Mol. Cell 6, 851–860 (2000)
Trusolino, L. et al. Growth factor-dependent activation of αvβ3 integrin in normal epithelial cells: Implications for tumor invasion. J. Cell Biol. 142, 1145–1156 (1998)
Neufeld, G. et al. The neuropilins: Multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc. Med. 12, 13–19 (2002)
Pasterkamp, R. J. & Kolodkin, A. L. Semaphorin junction: Making tracks toward neural connectivity. Curr. Opin. Neurobiol. 13, 79–89 (2003)
Miao, H. Q. et al. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: Functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell. Biol. 146, 233–242 (1999)
Kawasaki, T. et al. A requirement for neuropilin-1 in embryonic vessel formation. Development 126, 4895–4902 (1999)
Garlanda, C. & Dejana, E. Heterogeneity of endothelial cells. Specific markers. Arterioscler. Thromb. Vasc. Biol. 17, 1193–1202 (1997)
Geiger, B., Bershadsky, A., Pankov, R. & Yamada, K. M. Transmembrane crosstalk between the extracellular matrix and the cytoskeleton. Nature Rev. Mol. Cell Biol. 2, 793–805 (2001)
Beningo, K. A., Dembo, M., Kaverina, I., Small, J. V. & Wang, Y. L. Nascent focal adhesions are responsible for the generation of strong propulsive forces in migrating fibroblasts. J. Cell Biol. 153, 881–888 (2001)
Tamagnone, L. et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99, 71–80 (1999)
Brooks, P. C. et al. Antiintegrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 96, 1815–1822 (1995)
Kim, S., Bell, K., Mousa, S. A. & Varner, J. A. Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin. Am. J. Pathol. 156, 1345–1362 (2000)
Pampori, N. et al. Mechanisms and consequences of affinity modulation of integrin α(V)β(3) detected with a novel patch-engineered monovalent ligand. J. Biol. Chem. 274, 21609–21616 (1999)
Lauffenburger, D. A. & Horwitz, A. F. Cell migration: A physically integrated molecular process. Cell 84, 359–369 (1996)
Gu, J. et al. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J. Cell Biol. 146, 389–403 (1999)
Evans, H. M. On the development of the aortae, cardinal and umbilical veins, and the other blood vessels of vertebrate embryos from capillaries. Anat. Rec. 3, 498–518 (1909)
Sabin, F. R. Origin and development of the primitive vessels of the chick and of the pig. Contrib. Embryol. Carnegie Inst. Wash. 6, 61–124 (1917)
Logan, M. & Tabin, C. Targeted gene misexpression in chick limb buds using avian replication-competent retroviruses. Methods 14, 407–420 (1998)
Seifert, R., Zhao, B. & Christ, B. Cytokinetic studies on the aortic endothelium and limb bud vascularization in avian embryos. Anat. Embryol. (Berl.) 186, 601–610 (1992)
Cruz, M. T., Dalgard, C. L. & Ignatius, M. J. Functional partitioning of β1 integrins revealed by activating and inhibitory mAbs. J. Cell Sci. 110, 2647–2659 (1997)
Neugebauer, K. M. & Reichardt, L. F. Cell-surface regulation of β1-integrin activity on developing retinal neurons. Nature 350, 68–71 (1991)
Taniguchi, M. et al. Disruption of semaphorin III/D gene causes severe abnormality in peripheral nerve projection. Neuron 19, 519–530 (1997)
Behar, O., Golden, J. A., Mashimo, H., Schoen, F. J. & Fishman, M. C. Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature 383, 525–528 (1996)
Sigmund, C. D. Viewpoint: Are studies in genetically altered mice out of control? Arterioscler. Thromb. Vasc. Biol. 20, 1425–1429 (2000)
Feiner, L. et al. Targeted disruption of semaphorin 3C leads to persistent truncus arteriosus and aortic arch interruption. Development 128, 3061–3070 (2001)
Robson, P., Pichla, S., Zhou, B. & Baldwin, H. S. in Assembly of the Vasculature and its Regulation (ed. Tomanek, R. J.) 97–110 (Birkhauser, Boston, 2002)
Brown, C. B. et al. PlexinA2 and semaphorin signaling during cardiac neural crest development. Development 128, 3071–3080 (2001)
Tse, C., Xiang, R. H., Bracht, T. & Naylor, S. L. Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res. 62, 542–546 (2002)
Xiang, R. et al. Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice. Cancer Res. 62, 2637–2643 (2002)
Cho, S. Y. & Klemke, R. L. Purification of pseudopodia from polarized cells reveals redistribution and activation of Rac through assembly of a CAS/Crk scaffold. J. Cell Biol. 156, 725–736 (2002)
Kullander, K. & Klein, R. Mechanisms and functions of eph and ephrin signalling. Nature Rev. Mol. Cell Biol. 3, 475–486 (2002)
Miao, H., Burnett, E., Kinch, M., Simon, E. & Wang, B. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nature Cell Biol. 2, 62–69 (2000)
Grignani, F. et al. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res. 58, 14–19 (1998)
Primo, L., Roca, C., Ferrandi, C., Lanfrancone, L. & Bussolino, F. Human endothelial cells expressing polyoma middle T induce tumors. Oncogene 19, 3632–3641 (2000)
Hamburger, V. & Hamilton, H. L. A series of normal stages in development of the chick embryo. J. Morphol. 88, 49–92 (1951)
Adams, R. H. et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: Demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13, 295–306 (1999)
Acknowledgements
We thank S. Hughes for RCAS-BP(A) vector and Cla12 adaptor plasmid, T. Yagi for sema3A+/- mice, T. Byzova for suggestions, FAMARCO S.p.A. and SUSA TRASPORTI S.p.A. for white Leghorn chicken eggs, M. Lobianco for administrative assistance, and L. Trusolino and M. Arese for suggestions and comments on the manuscript. This work was supported by the Associazione Italiana per la Ricerca sul Cancro, Istituto Superiore di Sanità (IV Programma Nazionale di Ricerca sull'AIDS-2001 and Progetto “Tumour therapy”), Compagnia di San Paolo, Ministero dell'Istruzione, dell'Università e della Ricerca (60%, COFIN 2002, and Progetto Strategico Oncologia), FIRB (Progetto Ingegneria dei Tessuti) (to F.B.) and the Deutsche Forschungsgemeinschaft (to A.W.P.). M.T.-L. is an Investigator of the Howard Hughes Medical Institute.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare that they have no competing financial interests.
Rights and permissions
About this article
Cite this article
Serini, G., Valdembri, D., Zanivan, S. et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 424, 391–397 (2003). https://doi.org/10.1038/nature01784
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature01784
This article is cited by
-
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Journal of Experimental & Clinical Cancer Research (2024)
-
Stroma-targeting strategies in pancreatic cancer: a double-edged sword
Journal of Physiology and Biochemistry (2023)
-
Neuropilin 1 and its inhibitory ligand mini-tryptophanyl-tRNA synthetase inversely regulate VE-cadherin turnover and vascular permeability
Nature Communications (2022)
-
Neuropilin 1 regulates bone marrow vascular regeneration and hematopoietic reconstitution
Nature Communications (2021)
-
Skeleton-vasculature chain reaction: a novel insight into the mystery of homeostasis
Bone Research (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.